Company
United StatesPublic company, NYSE: NRXSNEURAXIS, INC (NYSE: NRXS), Carmel, IN – FDA Inspections
Inspection records and compliance data for NEURAXIS, INC in Carmel, Indiana. 1 FDA inspection on record, last inspected June 06, 2018. Publicly traded as NYSE: NRXS.
Company Profile
This profile covers NEURAXIS, INC based in Carmel, Indiana, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 6, 2018.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 6, 2018 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 1055858 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
NEURAXIS, INC
Stock ticker
NRXS
Exchange
NYSE
Share price
$6.05
Market cap
$75.9M
Price as of
November 6, 2026
FEI Number
3009293069
Address
11611 N Meridian St, Carmel, Indiana 46032-6953, United States
Country
United States
ID: 9a21a3ea-1471-459f-a2c1-516807b09dd5